Hepatic retransplantation

University of Nebraska Medical Center experience

S. Saito, Alan Norman Langnas, R. J. Stratta, R. P. Wood, Byers Wendell Shaw Jr, T. Matsuno, Rodney Smith Markin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The lack of an artificial liver makes liver retransplantation a unique, life-saving procedure when all the other alternatives to save a failed graft have been exhausted. On the other hand, the shortage of donors in line with the increasing number of end-stage liver disease patients who are waiting in long recipient lists represents a dilemma and raises the question of most appropriate recipient selection. In this report, we retrospectively analyzed the results of 350 primary, 48 secondary, and 5 tertiary hepatic transplants performed between July 1985 and January 1990 at University of Nebraska Medical Center. The same immunosuppression protocol was used in each case and the maintenance immunosuppressive therapy consisted of cyclosporine (CyA) and steroids. The overall survival rate of 80.5% at 1 year which was achieved in the primary grafting group was significantly better than the secondary grafting group (63.0%, p < 0.05). However, this difference was not significant in pediatric patients and their survival rates were 73.8% and 71.6% in primary and secondary grafting groups, respectively. When the retransplanted patients were considered as deaths unless secondary grafting was performed, the overall patient survival rate of 69.7% in primary grafting group at 1 yr increased to 77.8% in the retransplanted group and this difference was significant (p < 0.05). Blood loss and operating time were found to be lower in the retransplanted group. Furthermore, the decrease of the operating time in the retransplanted pediatric patients reached statistical significance (p < 0.05). Retransplantation of the liver, when compared with primary grafting, was not associated with any further technical difficulties and in the light of our results appeared to be even less troublesome, particularly in early retransplants. In conclusion, we believe that retransplantation of the liver has a significant impetus on patient survival and there are firm grounds for optimism about its future.

Original languageEnglish (US)
Pages (from-to)430-435
Number of pages6
JournalClinical Transplantation
Volume6
Issue number6
StatePublished - Jan 1 1992

Fingerprint

Liver
Survival Rate
Artificial Liver
Pediatrics
Transplants
End Stage Liver Disease
Immunosuppressive Agents
Immunosuppression
Cyclosporine
Steroids
Maintenance
Tissue Donors
Survival
Therapeutics

Keywords

  • Crossmatch
  • Liver transplantation
  • Retransplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Saito, S., Langnas, A. N., Stratta, R. J., Wood, R. P., Shaw Jr, B. W., Matsuno, T., & Markin, R. S. (1992). Hepatic retransplantation: University of Nebraska Medical Center experience. Clinical Transplantation, 6(6), 430-435.

Hepatic retransplantation : University of Nebraska Medical Center experience. / Saito, S.; Langnas, Alan Norman; Stratta, R. J.; Wood, R. P.; Shaw Jr, Byers Wendell; Matsuno, T.; Markin, Rodney Smith.

In: Clinical Transplantation, Vol. 6, No. 6, 01.01.1992, p. 430-435.

Research output: Contribution to journalArticle

Saito, S, Langnas, AN, Stratta, RJ, Wood, RP, Shaw Jr, BW, Matsuno, T & Markin, RS 1992, 'Hepatic retransplantation: University of Nebraska Medical Center experience', Clinical Transplantation, vol. 6, no. 6, pp. 430-435.
Saito S, Langnas AN, Stratta RJ, Wood RP, Shaw Jr BW, Matsuno T et al. Hepatic retransplantation: University of Nebraska Medical Center experience. Clinical Transplantation. 1992 Jan 1;6(6):430-435.
Saito, S. ; Langnas, Alan Norman ; Stratta, R. J. ; Wood, R. P. ; Shaw Jr, Byers Wendell ; Matsuno, T. ; Markin, Rodney Smith. / Hepatic retransplantation : University of Nebraska Medical Center experience. In: Clinical Transplantation. 1992 ; Vol. 6, No. 6. pp. 430-435.
@article{a032de71098f47fe96545d589a5f5558,
title = "Hepatic retransplantation: University of Nebraska Medical Center experience",
abstract = "The lack of an artificial liver makes liver retransplantation a unique, life-saving procedure when all the other alternatives to save a failed graft have been exhausted. On the other hand, the shortage of donors in line with the increasing number of end-stage liver disease patients who are waiting in long recipient lists represents a dilemma and raises the question of most appropriate recipient selection. In this report, we retrospectively analyzed the results of 350 primary, 48 secondary, and 5 tertiary hepatic transplants performed between July 1985 and January 1990 at University of Nebraska Medical Center. The same immunosuppression protocol was used in each case and the maintenance immunosuppressive therapy consisted of cyclosporine (CyA) and steroids. The overall survival rate of 80.5{\%} at 1 year which was achieved in the primary grafting group was significantly better than the secondary grafting group (63.0{\%}, p < 0.05). However, this difference was not significant in pediatric patients and their survival rates were 73.8{\%} and 71.6{\%} in primary and secondary grafting groups, respectively. When the retransplanted patients were considered as deaths unless secondary grafting was performed, the overall patient survival rate of 69.7{\%} in primary grafting group at 1 yr increased to 77.8{\%} in the retransplanted group and this difference was significant (p < 0.05). Blood loss and operating time were found to be lower in the retransplanted group. Furthermore, the decrease of the operating time in the retransplanted pediatric patients reached statistical significance (p < 0.05). Retransplantation of the liver, when compared with primary grafting, was not associated with any further technical difficulties and in the light of our results appeared to be even less troublesome, particularly in early retransplants. In conclusion, we believe that retransplantation of the liver has a significant impetus on patient survival and there are firm grounds for optimism about its future.",
keywords = "Crossmatch, Liver transplantation, Retransplantation",
author = "S. Saito and Langnas, {Alan Norman} and Stratta, {R. J.} and Wood, {R. P.} and {Shaw Jr}, {Byers Wendell} and T. Matsuno and Markin, {Rodney Smith}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "6",
pages = "430--435",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Hepatic retransplantation

T2 - University of Nebraska Medical Center experience

AU - Saito, S.

AU - Langnas, Alan Norman

AU - Stratta, R. J.

AU - Wood, R. P.

AU - Shaw Jr, Byers Wendell

AU - Matsuno, T.

AU - Markin, Rodney Smith

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The lack of an artificial liver makes liver retransplantation a unique, life-saving procedure when all the other alternatives to save a failed graft have been exhausted. On the other hand, the shortage of donors in line with the increasing number of end-stage liver disease patients who are waiting in long recipient lists represents a dilemma and raises the question of most appropriate recipient selection. In this report, we retrospectively analyzed the results of 350 primary, 48 secondary, and 5 tertiary hepatic transplants performed between July 1985 and January 1990 at University of Nebraska Medical Center. The same immunosuppression protocol was used in each case and the maintenance immunosuppressive therapy consisted of cyclosporine (CyA) and steroids. The overall survival rate of 80.5% at 1 year which was achieved in the primary grafting group was significantly better than the secondary grafting group (63.0%, p < 0.05). However, this difference was not significant in pediatric patients and their survival rates were 73.8% and 71.6% in primary and secondary grafting groups, respectively. When the retransplanted patients were considered as deaths unless secondary grafting was performed, the overall patient survival rate of 69.7% in primary grafting group at 1 yr increased to 77.8% in the retransplanted group and this difference was significant (p < 0.05). Blood loss and operating time were found to be lower in the retransplanted group. Furthermore, the decrease of the operating time in the retransplanted pediatric patients reached statistical significance (p < 0.05). Retransplantation of the liver, when compared with primary grafting, was not associated with any further technical difficulties and in the light of our results appeared to be even less troublesome, particularly in early retransplants. In conclusion, we believe that retransplantation of the liver has a significant impetus on patient survival and there are firm grounds for optimism about its future.

AB - The lack of an artificial liver makes liver retransplantation a unique, life-saving procedure when all the other alternatives to save a failed graft have been exhausted. On the other hand, the shortage of donors in line with the increasing number of end-stage liver disease patients who are waiting in long recipient lists represents a dilemma and raises the question of most appropriate recipient selection. In this report, we retrospectively analyzed the results of 350 primary, 48 secondary, and 5 tertiary hepatic transplants performed between July 1985 and January 1990 at University of Nebraska Medical Center. The same immunosuppression protocol was used in each case and the maintenance immunosuppressive therapy consisted of cyclosporine (CyA) and steroids. The overall survival rate of 80.5% at 1 year which was achieved in the primary grafting group was significantly better than the secondary grafting group (63.0%, p < 0.05). However, this difference was not significant in pediatric patients and their survival rates were 73.8% and 71.6% in primary and secondary grafting groups, respectively. When the retransplanted patients were considered as deaths unless secondary grafting was performed, the overall patient survival rate of 69.7% in primary grafting group at 1 yr increased to 77.8% in the retransplanted group and this difference was significant (p < 0.05). Blood loss and operating time were found to be lower in the retransplanted group. Furthermore, the decrease of the operating time in the retransplanted pediatric patients reached statistical significance (p < 0.05). Retransplantation of the liver, when compared with primary grafting, was not associated with any further technical difficulties and in the light of our results appeared to be even less troublesome, particularly in early retransplants. In conclusion, we believe that retransplantation of the liver has a significant impetus on patient survival and there are firm grounds for optimism about its future.

KW - Crossmatch

KW - Liver transplantation

KW - Retransplantation

UR - http://www.scopus.com/inward/record.url?scp=0027027671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027027671&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 430

EP - 435

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 6

ER -